2025-02-11 09:02:38

The latest status of anti-cancer drugs in the country's pharmaceutical list

The Head of the Committee for Review and Compilation of the Iranian Pharmaceutical List, while referring to the latest status of anti-cancer drugs in the official pharmaceutical list of the country, stated that the pharmaceutical list of the country is ready to accept targeted treatments in this field, but pharmaceutical companies must introduce effective and cost-effective molecules.
https://www.entekhab.ir/fa/news/850123/%D8%A2%D8%AE%D8%B1%DB%8C%D9%86-%D9%88%D8%B6%D8%B9%DB%8C%D8%AA-%D8%AF%D8%A7%D8%B1%D9%88%D9%87%D8%A7%DB%8C-%D8%B6%D8%AF-%D8%B3%D8%B1%D8%B7%D8%A7%D9%86-%D8%AF%D8%B1-%D9%81%D9%87%D8%B1%D8%B3%D8%AA-%D8%AF%D8%A7%D8%B1%D9%88%DB%8C%DB%8C-%DA%A9%D8%B4%D9%88%D8%B1

Author Public Key

npub1l6z9qujmt0aylm4u27pc58c0qpp5td3aa3h6lhpszdzn30pnzlzqj03ytw

Show more details

Published at

2025-02-11 09:02:38

Kind type

1 Short Text Note

Event JSON

{ "id": "e34db91e0d10825234f4771399acd127ae909b0acae2b4071870110567536fc0", "pubkey": "fe8450725b5bfa4feebc57838a1f0f004345b63dec6fafdc30134538bc3317c4", "created_at": 1739264558, "kind": 1, "tags": [ [ "r", "https://www.entekhab.ir/fa/news/850123/%D8%A2%D8%AE%D8%B1%DB%8C%D9%86-%D9%88%D8%B6%D8%B9%DB%8C%D8%AA-%D8%AF%D8%A7%D8%B1%D9%88%D9%87%D8%A7%DB%8C-%D8%B6%D8%AF-%D8%B3%D8%B1%D8%B7%D8%A7%D9%86-%D8%AF%D8%B1-%D9%81%D9%87%D8%B1%D8%B3%D8%AA-%D8%AF%D8%A7%D8%B1%D9%88%DB%8C%DB%8C-%DA%A9%D8%B4%D9%88%D8%B1" ], [ "subject", "The latest status of anti-cancer drugs in the country's pharmaceutical list" ], [ "published_at", "1739262551" ], [ "image", "https://cdn.entekhab.ir/files/fa/news/1403/11/23/1914450_820.jpeg" ], [ "p", "fe8450725b5bfa4feebc57838a1f0f004345b63dec6fafdc30134538bc3317c4", "wss://articles.layer3.news" ], [ "imeta", "url https://cdn.entekhab.ir/files/fa/news/1403/11/23/1914450_820.jpeg" ], [ "t", "eastern-bloc:perspective" ], [ "summary", "The Iranian Food and Drug Administration is preparing to accept targeted cancer treatments, but companies must provide effective and cost-effective molecules. The administration has already registered 18 out of 21 alkylating agents and 11 out of 19 antimetabolites, but there is a need for investment and precise policy-making to access new and more expensive treatments. The use of artificial intelligence in designing and producing drugs is expected to revolutionize the field, but there is a growing gap in access to these expensive and vital medicines." ] ], "content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpql6z9qujmt0aylm4u27pc58c0qpp5td3aa3h6lhpszdzn30pnzlzq3ayla7\nhttps://cdn.entekhab.ir/files/fa/news/1403/11/23/1914450_820.jpeg\nThe Head of the Committee for Review and Compilation of the Iranian Pharmaceutical List, while referring to the latest status of anti-cancer drugs in the official pharmaceutical list of the country, stated that the pharmaceutical list of the country is ready to accept targeted treatments in this field, but pharmaceutical companies must introduce effective and cost-effective molecules.\nhttps://www.entekhab.ir/fa/news/850123/%D8%A2%D8%AE%D8%B1%DB%8C%D9%86-%D9%88%D8%B6%D8%B9%DB%8C%D8%AA-%D8%AF%D8%A7%D8%B1%D9%88%D9%87%D8%A7%DB%8C-%D8%B6%D8%AF-%D8%B3%D8%B1%D8%B7%D8%A7%D9%86-%D8%AF%D8%B1-%D9%81%D9%87%D8%B1%D8%B3%D8%AA-%D8%AF%D8%A7%D8%B1%D9%88%DB%8C%DB%8C-%DA%A9%D8%B4%D9%88%D8%B1", "sig": "8ce5480f1e71011a24aa9f5b33cea6baaa2521d291cd720a74e9ff36dee6b69ed7d03771ffd7976c5e435cede8f23823793cd0ce4da28ced98271d8de4d0b8af" }